FDA Adverse Event
Injury
Summary report: N
STRATTICE RECONSTRUCTIVE TISSUE MATRIX, 20 X 20, FIRM
MDR report key: 11991263
·
Received June 14, 2021
Report
- Report Number
- 1000306051-2021-03005
- Event Type
- Injury
- Date Received
- June 14, 2021
- Date of Event
- January 18, 2010
- Manufacturer
- LIFECELL
- Product Code
- FTM
- PMA / PMN Number
- K070560
- Adverse Event
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- PA, US
- Reporter Occupation
- 003
Narratives
Additional Manufacturer Narrative · 1
QA INVESTIGATION INTO LOT S10546 RESULTED IN NO REMARKABLE FINDINGS AND NO DEVIATIONS AND NO NONCONFROMANCES REVEALED. (B)(4) DEVICES WERE RELEASED TO FINISHED GOODS.(B)(4) REPORTED AS IMPLANTED (B)(4) HAVE BEEN DISTRIBUTED. NO OTHER COMPLAINTS AGAINST. LOT S10546 WERE REVEALED. LOT S10546 WAS ASEPTICALLY PROCESSED, TERMINALLY STERILIZED AND MET ALL QC RELEASE CRITERIA.
Description of Event or Problem · 1
PATIENT REPRESENTATIVE REPORTS A (B)(6) YO MALE PATIENT HAD A HERNIA REPAIR WITH STRATTICE ON (B)(6) 2009. ON (B)(6) 2010, A REMOVAL OF THE MESH WAS REQUIRED AND A REPAIR OF THE INCISIONAL HERNIA. PARTIAL KNOWN LOT S10546 CATALOG 2020002.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 888757 | STRATTICE RECONSTRUCTIVE TISSUE MATRIX, 20 X 20, FIRM | MESH, SURGICAL | FTM | LIFECELL | S10546 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | 42 YR | Required Intervention |